How I treat patients who mobilize hematopoietic stem cells poorly
LB To, JP Levesque, KE Herbert - Blood, The Journal of the …, 2011 - ashpublications.org
Abstract Transplantation with 2-5× 106 mobilized CD34+ cells/kg body weight lowers
transplantation costs and mortality. Mobilization is most commonly performed with …
transplantation costs and mortality. Mobilization is most commonly performed with …
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial
ZD Crees, MP Rettig, RG Jayasinghe… - Nature medicine, 2023 - nature.com
Autologous hematopoietic stem cell transplantation (ASCT) improves survival in multiple
myeloma (MM). However, many individuals are unable to collect optimal CD34+ …
myeloma (MM). However, many individuals are unable to collect optimal CD34+ …
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
JF DiPersio, EA Stadtmauer… - Blood, The Journal …, 2009 - ashpublications.org
Abstract This phase 3, multicenter, randomized (1: 1), double-blind, placebo-controlled study
evaluated the safety and efficacy of plerixafor with granulocyte colony-stimulating factor (G …
evaluated the safety and efficacy of plerixafor with granulocyte colony-stimulating factor (G …
[HTML][HTML] Systematic review of randomized controlled trials of hematopoietic stem cell mobilization strategies for autologous transplantation for hematologic …
Collection of adequate hematopoietic stem cells (HSCs) is necessary for successful
autologous transplantation; however, a proportion of patients fail to collect the minimum …
autologous transplantation; however, a proportion of patients fail to collect the minimum …
The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone
N Flomenberg, SM Devine, JF DiPersio, JL Liesveld… - Blood, 2005 - ashpublications.org
Hematopoietic progenitor cells (HPCs) traffic to and are retained in the marrow through the
trophic effects of the chemokine stromal cell-derived factor-1α (SDF-1α) binding to its …
trophic effects of the chemokine stromal cell-derived factor-1α (SDF-1α) binding to its …
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma
DG Maloney, AJ Molina, F Sahebi… - Blood, 2003 - ashpublications.org
The full potential of a graft-versusmyeloma effect after allogeneic hematopoietic cell
transplantation (HCT) for patients with multiple myeloma (MM) has not been realized …
transplantation (HCT) for patients with multiple myeloma (MM) has not been realized …
Proposed definition of 'poor mobilizer'in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo …
Many lymphoma and myeloma patients fail to undergo ASCT owing to poor mobilization.
Identification of poor mobilizers (PMs) would provide a tool for early intervention with new …
Identification of poor mobilizers (PMs) would provide a tool for early intervention with new …
[HTML][HTML] Transplanted CD34+ cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with …
PJ Stiff, I Micallef, AP Nademanee… - Biology of Blood and …, 2011 - Elsevier
Autologous hematopoietic stem cell transplantation (ASCT) is an established treatment for
patients with hematologic malignancies, yet the impact of transplanted CD34+ cell dose on …
patients with hematologic malignancies, yet the impact of transplanted CD34+ cell dose on …
Mobilization of CD34+ cells in elderly patients (≥ 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen
CL Morris, E Siegel, B Barlogie… - British journal of …, 2003 - Wiley Online Library
The mobilization of peripheral blood stem cells was studied in 984 multiple myeloma
patients, including 106 patients aged≥ 70 years. Increasing age correlated inversely with …
patients, including 106 patients aged≥ 70 years. Increasing age correlated inversely with …
Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma
We retrospectively analyzed outcomes of 716 patients with multiple myeloma who were
mobilized using CY and growth factor (n= 370) or growth factor alone (n= 346) before SCT …
mobilized using CY and growth factor (n= 370) or growth factor alone (n= 346) before SCT …